The new specialist firm will operate across the North American, APAC and European markets, which make up around 90% of the global R&D spend.
The new firm will focus on “high-growth, innovation-led” healthcare investment opportunities, including AI-related projects. Credit: eamesBot / Shutterstock.com.
Two key healthcare investors have merged to create the largest dedicated investment manager in their specialist sector, which will see the duo hold more than $21bn in combined assets.
Through the deal between European specialist healthcare investor, Global Healthcare Opportunities (GHO) and Asian asset manager, CBC Group, the two companies will join forces to serve companies in the pharma, life sciences, diagnostics, medtech and healthcare sectors. Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
